SCHEMBL356681

SCHEMBL356681

Cc1ccc(=O)n(-c2ccc(-n3cc(C)ccc3=O)cc2)c1

nearest known ligand 0.80

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.80
KDM4E B2RXH2 2/20 0.80
CYP1A2 P05177 1/20 0.80
HPGD P15428 1/20 0.80
BLM P54132 1/20 0.80
HSD17B10 Q99714 1/20 0.80
MAPK14 Q16539 5/20 0.57
ELANE P08246 2/20 0.44
F2 P00734 1/20 0.44
CTSG P08311 1/20 0.44
CMA1 P23946 1/20 0.44
CTRC Q99895 1/20 0.44
POLB P06746 1/20 0.42
MAPT P10636 1/20 0.42
MGLL Q99685 1/20 0.41
PKM P14618 1/20 0.40
COMT P21964 1/20 0.40
LMNA P02545 2/20 0.39
RGS4 P49798 1/20 0.38
RGS8 P57771 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3970272 0.98 ALDH1A1 (0.77) ALDH1A1KDM4ECYP1A2HPGDBLM
SCHEMBL9892413 0.90 ALDH1A1 (0.67) ALDH1A1KDM4ECYP1A2HPGDBLM
Hydronidone SCHEMBL143564 0.90 ALDH1A1 (0.67) ALDH1A1KDM4ECYP1A2HPGDBLM
SCHEMBL147877 0.90 ALDH1A1 (0.67) ALDH1A1KDM4ECYP1A2HPGDBLM
SCHEMBL3307167 0.90 ALDH1A1 (0.67) ALDH1A1KDM4ECYP1A2HPGDBLM
SCHEMBL3975362 0.90 ALDH1A1 (0.67) ALDH1A1KDM4ECYP1A2HPGDBLM
SCHEMBL3302369 0.90 ALDH1A1 (0.67) ALDH1A1KDM4ECYP1A2HPGDBLM
Pirfenidone SCHEMBL4708 0.89 KDM4E (1.00) ALDH1A1KDM4ECYP1A2HPGDBLM
Pirfenidone SCHEMBL1006039 0.89 KDM4E (1.00) ALDH1A1KDM4ECYP1A2HPGDBLM
Pirfenidone SCHEMBL22492268 0.87 KDM4E (0.96) ALDH1A1KDM4ECYP1A2HPGDBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 46 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150368200-A1 METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. 2015-12-24 US claimed
US-20150065720-A1 METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. 2015-03-05 US claimed
US-20140221660-A1 METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. (US) 2014-08-07 US claimed
US-20130345430-A1 METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. (US) 2013-12-26 US claimed
EP-2440543-A2 IMPROVED METHOD FOR SYNTHESIZING PIRFENIDONE Intermune, Inc. (US) 2012-04-18 EP claimed
US-20120016133-A1 Method for Synthesizing Pirfenidone INTERMUNE, INC. (US) 2012-01-19 US claimed
US-20110003863-A1 METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. (US) 2011-01-06 US claimed
WO-2010141600-A2 IMPROVED METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. (US) 2010-12-09 WO claimed
US-11066368-B2 Process for the preparation and particle size reduction of pirfenidone LAURUS LABS LIMITED (IN) 2021-07-20 US disclosed
WO-2017130166-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF HIGHLY PURE ANTI-FIBROTIC DRUG GRANULES INDIA LIMITED (IN) 2017-08-03 WO disclosed
WO-2017122139-A1 AN IMPROVED PROCESS FOR THE PREPARATION OF PIRFENIDONE LAURUS LABS LIMITED (IN) 2017-07-20 WO disclosed
US-20150368200-A1 METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. 2015-12-24 US disclosed
US-20150368200-A1 METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. 2015-12-24 US disclosed
US-20150368200-A1 METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. 2015-12-24 US disclosed
US-20110003863-A1 METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. (US) 2011-01-06 US disclosed
US-20110003863-A1 METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. (US) 2011-01-06 US disclosed
US-20110003863-A1 METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. (US) 2011-01-06 US disclosed
WO-2010141600-A2 IMPROVED METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. (US) 2010-12-09 WO disclosed
WO-2010141600-A2 IMPROVED METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. (US) 2010-12-09 WO disclosed
WO-2010141600-A2 IMPROVED METHOD FOR SYNTHESIZING PIRFENIDONE INTERMUNE, INC. (US) 2010-12-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11066368-B2 Process for the preparation and particle size reduction of pirfenidone PIR, FIP1L1, RPLP1 ALDH1A1 2893/4885KDM4E 1149/4885CYP1A2 1031/4885
US-20120016133-A1 Method for Synthesizing Pirfenidone BRPF1, CYP2B6, CYP26B1 ALDH1A1 138/4885KDM4E 587/4885CYP1A2 28/4885
US-20150065720-A1 METHOD FOR SYNTHESIZING PIRFENIDONE BRPF1, CYP2B6, CYP26B1 ALDH1A1 138/4885KDM4E 587/4885CYP1A2 28/4885
US-20110003863-A1 METHOD FOR SYNTHESIZING PIRFENIDONE BRPF1, CYP2B6, CYP26B1 ALDH1A1 137/4885KDM4E 937/4885CYP1A2 24/4885
US-20150368200-A1 METHOD FOR SYNTHESIZING PIRFENIDONE BRPF1, CYP2B6, CYP26B1 ALDH1A1 138/4885KDM4E 587/4885CYP1A2 28/4885
US-20130345430-A1 METHOD FOR SYNTHESIZING PIRFENIDONE BRPF1, CYP2B6, CYP26B1 ALDH1A1 138/4885KDM4E 587/4885CYP1A2 28/4885
US-20140221660-A1 METHOD FOR SYNTHESIZING PIRFENIDONE BRPF1, CYP2B6, CYP26B1 ALDH1A1 138/4885KDM4E 587/4885CYP1A2 28/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.